Japanese pharmaceutical companies have been among the most vocal in the sector to express their concerns about Brexit and it seems that one of them – Shionogi & Co. Ltd. – is planning to move its Europe base from London to the Netherlands as the March 29 deadline for the UK to leave the European Union looms large.
According to the Financial Times, which cited unnamed people who have been briefed on the matter, Shionogi intends to merge...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?